Univariate analysis showed CS infection, tumor location, cancer stage, tumor differentiation, treatment intent, CA 19-9, CEA, and total bilirubin are associated with overall survival in CCA patients under 64 years old. This evidence concerns the gene CEACAM5 and cholangiocarcinoma.